Vinayak Doraiswamy Atri Cure, Inc. (ATRC) insider trading activity
Vinayak Doraiswamy is Chief Scientific Officer of AtriCure, Inc.. Currently has a direct ownership of 76,050 shares of ATRC, which is worth approximately $2.53 Million. The most recent transaction as insider was on Mar 01, 2025, when has been sold 9,672 shares (Common Stock) at a price of $38.74 per share, resulting in proceeds of $374,693. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
76.1K
27.21%
3M change
28.73%
12M change
Total Value Held
$2.53 Million
Vinayak Doraiswamy Transaction History
VD
Vinayak Doraiswamy
Chief Scientific Officer
Mason, OH